X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (291) 291
cardiac & cardiovascular systems (203) 203
male (165) 165
female (154) 154
index medicus (145) 145
middle aged (129) 129
aged (115) 115
aspirin (86) 86
treatment outcome (76) 76
risk factors (62) 62
atrial fibrillation (60) 60
warfarin (60) 60
myocardial infarction - drug therapy (59) 59
abridged index medicus (58) 58
anticoagulants (56) 56
stroke (53) 53
therapy (53) 53
heart attacks (52) 52
platelet aggregation inhibitors - therapeutic use (49) 49
anticoagulants - therapeutic use (47) 47
acute myocardial-infarction (46) 46
peripheral vascular disease (46) 46
prevention (46) 46
medicine, general & internal (45) 45
mortality (44) 44
risk (43) 43
cardiology (42) 42
clopidogrel (42) 42
anticoagulants - administration & dosage (40) 40
myocardial infarction (40) 40
hemorrhage - chemically induced (39) 39
myocardial-infarction (39) 39
percutaneous coronary intervention (39) 39
time factors (39) 39
drug therapy, combination (38) 38
follow-up studies (38) 38
aspirin - therapeutic use (37) 37
atrial fibrillation - drug therapy (37) 37
fibrinolytic agents - therapeutic use (36) 36
acute coronary syndromes (35) 35
care and treatment (35) 35
anticoagulants - adverse effects (34) 34
atrial fibrillation - complications (34) 34
thrombolytic therapy (33) 33
prognosis (32) 32
management (31) 31
hematology (30) 30
administration, oral (29) 29
adult (29) 29
drug therapy (29) 29
angioplasty (28) 28
antiplatelet therapy (28) 28
medicine & public health (28) 28
prospective studies (28) 28
stroke - prevention & control (28) 28
bleeding (27) 27
heart attack (27) 27
thrombolysis (27) 27
clinical trials (26) 26
cardiac patients (25) 25
cardiovascular (25) 25
cardiovascular disease (25) 25
randomized controlled trials as topic (25) 25
antithrombotic therapy (24) 24
coronary heart disease (24) 24
double-blind method (24) 24
electrocardiography (24) 24
ticlopidine - analogs & derivatives (24) 24
heart failure (23) 23
myocardial infarction - prevention & control (23) 23
patients (23) 23
angioplasty, balloon, coronary (22) 22
aspirin - administration & dosage (22) 22
myocardial infarction - therapy (22) 22
research (22) 22
risk assessment (22) 22
cardiac arrhythmia (21) 21
cardiovascular diseases (21) 21
metaanalysis (21) 21
myocardial infarction - mortality (21) 21
platelet aggregation inhibitors - administration & dosage (21) 21
rivaroxaban (21) 21
thrombosis (21) 21
trial (21) 21
acute coronary syndrome (19) 19
platelet aggregation inhibitors - adverse effects (19) 19
secondary prevention (19) 19
acute coronary syndrome - drug therapy (18) 18
coronary angiography (18) 18
coronary vessels (18) 18
hemorrhage (18) 18
intervention (18) 18
recurrence (18) 18
thrombolytic therapy - methods (18) 18
aged, 80 and over (17) 17
cardiology and cardiovascular medicine (17) 17
clinical trials as topic (17) 17
dabigatran (17) 17
double-blind (17) 17
events (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and haemostasis, ISSN 0340-6245, 2019, Volume 19, p. 1553
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 1, pp. 9 - 19
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 11, pp. 981 - 992
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2008, Volume 118, Issue 16, pp. 1626 - 1636
BACKGROUND: Patients with diabetes mellitus (DM) are at high risk for recurrent cardiovascular events after acute coronary syndromes, in part because of... 
Myocardial infarction | Anticoagulants | Platelets | Angioplasty | Diabetes mellitus | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CARDIOVASCULAR OUTCOMES | STENT THROMBOSIS | myocardial infarction | diabetes mellitus | ASPIRIN | platelets | INSULIN | PERCUTANEOUS CORONARY INTERVENTION | CLOPIDOGREL | anticoagulants | PERIPHERAL VASCULAR DISEASE | AGGREGATION | angioplasty | ARTERY-DISEASE | Piperazines - administration & dosage | Prasugrel Hydrochloride | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Diabetes Mellitus, Type 1 - complications | Hypoglycemic Agents - administration & dosage | Coronary Thrombosis - complications | Platelet Aggregation Inhibitors - administration & dosage | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Administration, Oral | Kaplan-Meier Estimate | Insulin - administration & dosage | Treatment Outcome | Coronary Thrombosis - drug therapy | Myocardial Ischemia - drug therapy | Ticlopidine - analogs & derivatives | Diabetes Mellitus, Type 1 - drug therapy | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Myocardial Ischemia - complications | Aged | Care and treatment | Prognosis | Development and progression | Diabetes | Research | Cardiovascular diseases | Heart attack
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 5, p. e63479
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 8, pp. 699 - 708
Journal Article